This revealed three different cancer subsets based on i) enrichment of EPHB2+ cells and lack of ERBB3+ cells, ii) absence of EPHB2+ cells or iii) the presence of both ERBB3+ and EPHB2+ cancer cell populations. This evidence concerns the gene EPHB2 and cancer.